VUNO scores government approval for at-home ECG device
Medical AI developer VUNO has received the approval of the Ministry of Food and Drug Safety (MFDS) for its at-home ECG device.
Called Hativ P30, the medical device not only provides a 6-lead heart signal measurement within 30 seconds, but it also analyses data to check for sinus rhythm, atrial fibrillation, bradycardia, and tachycardia.
The...
Singapore clears VUNO's AI software for fundus analysis
South Korean medical AI firm VUNO has recently obtained a medical device certification from Singapore's Health Sciences Authority for its AI-based fundus analysis software.
The VUNO Med-Fundus AI analyses images of the fundus, which is the back part of the eye, to provide findings necessary for the diagnosis of retinal diseases. It can...
Latest research integrates artificial intelligence into retinal imaging to detect and monitor eye diseases on a large scale.
The Comprehensive AI Retinal Expert (CARE) system was developed by a team of researchers from four institutions in China: Sun Yat-sen University, Beijing Eaglevision Technology, Beijing Tongren Eye Centre and Capital Medical University, together with the Monash University...
Samsung has developed a medical device that uses older models of its Galaxy smartphone line to screen for eye diseases in underserved areas.
The global electronics firm teamed up with International Agency for the Prevention of Blindness and Yonsei University Health System in South Korea to create the EYELIKE fundus camera under its Galaxy Upcycling programme, which started in 2017.
WHAT IT DOES...
Eggs, milk, remote care. Thanks to a partnership between Texas grocery chain H-E-B and Reliant Immune Diagnostics, consumers seeking a mobile telemedicine consultation can purchase an appointment while stocking up the fridge.
The free-to-download MDBox platform offers symptom-driven video consultations and prescriptions from licensed providers for a flat, upfront fee. Now, patients can visit the...
GoCheck, maker of a smartphone app that screens young children for amblyopia or “lazy eye,” has raised $6 million in a Series B investment round headed by FCA Venture Partners. Other new backers Mucker Capital and Sovereign’s Capital will join the company’s prior investors, which include Interwest Partners and Marc Benioff.
WHAT THEY DO
GoCheck (formerly Gobiquity Mobile Health, and iCheck Health...
